A detailed history of S. Muoio & Co. LLC transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, S. Muoio & Co. LLC holds 18,980 shares of BHVN stock, worth $686,127. This represents 3.79% of its overall portfolio holdings.

Number of Shares
18,980
Previous 13,500 40.59%
Holding current value
$686,127
Previous $1.97 Million 45.86%
% of portfolio
3.79%
Previous 2.8%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$144.95 - $152.29 $794,325 - $834,549
5,480 Added 40.59%
18,980 $2.87 Million
Q2 2022

Aug 15, 2022

BUY
$83.14 - $145.99 $1.12 Million - $1.97 Million
13,500 New
13,500 $1.97 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.59B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track S. Muoio & Co. LLC Portfolio

Follow S. Muoio & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S. Muoio & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on S. Muoio & Co. LLC with notifications on news.